1108674--3/13/2007--STRATAGENE_

related topics

{product, market, service}

{stock, price, operating}

{acquisition, growth, future}

{property, intellectual, protect}

{product, liability, claim}

{cost, contract, operation}

{product, candidate, development}

{customer, product, revenue}

{operation, international, foreign}

{personnel, key, retain}

{stock, price, share}

{control, financial, internal}

{cost, regulation, environmental}

{provision, law, control}

{debt, indebtedness, cash}

{system, service, information}

Our future success depends on the timely introduction of new products and the acceptance of these new products in the marketplace. The markets for our products are extremely competitive and subject to rapid technological change. If we fail to compete effectively, our business may suffer. We may be prevented from selling some of our products if our existing license agreements are terminated. Because our quarterly revenue and operating results may vary significantly in future periods, our stock price may decline. Our founder, chairman of our board of directors, chief executive officer and president exerts considerable control over our business. We depend substantially on key employees, and losing the services of any of our key employees or failing to hire qualified employees could seriously damage our business. Our indebtedness could limit our ability to operate our business, obtain additional financing and pursue other business opportunities. We may not have financing for future capital requirements, which may have a material adverse effect on our business. Our inability to secure and maintain intellectual property protection for our products and technologies could adversely affect our ability to compete. We are currently, and could in the future be, subject to lawsuits, arbitrations, and other legal actions, particularly involving claims for infringement of patents and other intellectual property rights. We may spend resources on research and development projects without being able to achieve an adequate return, if any, on our investment. Our business could suffer if we fail to manage our growth effectively. Our stock price could be adversely affected if we are unable to implement and maintain effective internal control over financial reporting. The price of our common stock is expected to be volatile. Future sales of currently outstanding shares of our common stock could adversely affect our stock price. Reductions in research and development budgets or government funding may impact our sales. Failure to license new technologies could impair our new product development. We may acquire other businesses or form joint ventures that could decrease our profitability, dilute your ownership, increase our debt or cause us to incur significant expense. Changes in distribution and purchasing methods by our customers may force us to use more expensive marketing and distribution channels. We rely on third party manufacturers for raw materials and product components. Adverse developments affecting our international operations or foreign currency fluctuations could harm our results from operations. Our activities involve hazardous materials and may subject our business to costly environmental liability. Interruptions in our manufacturing operations could adversely impact our ability to effectively operate our business. We could incur substantial unexpected expenses, experience product returns and suffer damage to our brand and reputation if our biological products and instruments are not properly produced or manufactured. Our business could suffer if our access to necessary tissue samples is restricted or ethical concerns surrounding the use of genetic information become widespread. Anti-takeover provisions of our certificate of incorporation and bylaws and provisions of Delaware law could delay or prevent a change of control that you may favor.

Full 10-K form ▸

1108674--3/13/2007--STRATAGENE__CORP